Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Deoxyuridine-5'-Triphosphate (dUTP) is a naturally occurring nucleotide, serving as a fundamental building block for DNA synthesis. It acts as a substrate for DNA polymerases, which incorporate it into nucleic acid strands. Additionally, dUTP is a substrate for the enzyme deoxyuridine-5'-triphosphate nucleotidohydrolase (dUTPase), an enzyme crucial in pyrimidine metabolism and identified as a target for cancer therapies, particularly in colorectal cancer. Modified forms of dUTP are widely employed in biophysical and biotechnology applications as nucleotide probes, for instance, in real-time monitoring of polymerase activity or for direct voltammetric detection of DNA. It is also a key component in diagnostic assays such as terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) for detecting apoptosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Deoxyuridine-5'-Triphosphate.